RE: So Easy. IMO28 Sep 2019 16:09
Ray,
Yes, it is easy to be concerned and quite right to be concerned. There is a real danger that we will miss the Melanoma boat despite the great results simply because we took too long. What looks best, 52% survival in 315 patients or 80% in 25 patients? I guess with BSM, this won’t be long to market.
The same could happen with SCIB2, then Moditope. All we will be left with is a few advanced royalties on Avidimab.
Sorry to paint such a bleak picture. I really do hope we get our act together and get some of these products to market or sell them to someone who can.
I own belief is that in the next 25 years, a new, effective cancer treatment will be developed that will replace all current methods including immunotherapy. It will be something that no one has dreamed of yet.
AIMVHO.